Literature DB >> 9703395

A-W glass ceramic as a bone substitute in cemented hip arthroplasty: 15 hips followed 2-10 years.

K Kawanabe1, H Iida, Y Matsusue, H Nishimatsu, R Kasai, T Nakamura.   

Abstract

We retrospectively reviewed hip arthroplasties in 13 patients (15 hips), in whom we had used apatite-wollastonite (A-W) glass ceramic together with auto- or allograft for augmentation of severe bone deficiency. 11 cemented sockets and 4 stem revisions were included and followed for 2-9.6 years. There were no radiolucent lines between A-W glass ceramic and surrounding bone, and remodeling of the bone graft containing A-W glass ceramic was observed. No migration of cemented sockets was seen except in 1 case, which was revised. In this case, direct bonding between bone and A-W glass ceramic granules was present histologically. In 4 stem revisions, 5 mm subsidence occurred in 1 case. However, the stem became stable and remodeling of the grafted bone occurred. An artificial bone material, such as A-W glass ceramic, can be used under high-load conditions, because of its good mechanical properties.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9703395     DOI: 10.3109/17453679809000922

Source DB:  PubMed          Journal:  Acta Orthop Scand        ISSN: 0001-6470


  3 in total

1.  In vivo absorption of porous apatite- and wollastonite-containing glass-ceramic.

Authors:  Kunitaka Ohsawa; Masashi Neo; Tsuyoshi Okamoto; Jiro Tamura; Takashi Nakamura
Journal:  J Mater Sci Mater Med       Date:  2004-08       Impact factor: 3.896

2.  Impaction grafting of the acetabulum with ceramic bone graft substitute: high survivorship in 43 patients with a mean follow-up period of 4 years.

Authors:  Michael R Whitehouse; Peter J Dacombe; Jason C J Webb; Ashley W Blom
Journal:  Acta Orthop       Date:  2013-08       Impact factor: 3.717

3.  Impaction grafting of the acetabulum with ceramic bone graft substitute mixed with femoral head allograft: high survivorship in 43 patients with a median follow-up of 7 years: a follow-up report.

Authors:  Michael R Whitehouse; Peter J Dacombe; Jason C J Webb; Ashley W Blom
Journal:  Acta Orthop       Date:  2013-04-17       Impact factor: 3.717

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.